See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Holi
Natural Disasters
Social Media
Baseball
Artificial Intelligence
Senate
Boxing
Stock Markets
Donald Trump
Vladimir Putin
South America
Basketball
Published • loading... • Updated

Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe

Summary by Benzinga
SHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced a distribution and marketing partnership with LEO Pharma for toripalimab in Europe. T…

5 Articles

All
Left
Center
1
Right
1
BenzingaBenzinga
Reposted by
Financial PostFinancial Post

Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe

SHANGHAI, Jan. 20, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced a distribution and marketing partnership with LEO Pharma for toripalimab in Europe. T…

·New York, United States
Read Full Article
pharmaceutical-technology.compharmaceutical-technology.com

Junshi to partner LEO Pharma for toripalimab distribution

Junshi Biosciences and TopAlliance are set to enter a collaboration with LEO Pharma to distribute and market toripalimab in Europe.

Read Full Article
pipelinereviewpipelinereview

Junshi Biosciences Announces Commercialization Partnership with LEO Pharma for Toripalimab in Europe - Pipelinereview

SHANGHAI, China I January 20, 2025 I Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced a distribution and marketing partnership with LEO Pharma for toripalimab in Europe. This col…

Read Full Article
European Medical JournalEuropean Medical Journal

LEO Pharma to market Junshi Biosciences's toripalimab

Shanghai-based Junshi Biosciences has announced a partnership with Denmark’s LEO Pharma to distribute and commercialise the drug in Europe.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources are Center, 50% of the sources lean Right
50% Right
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Benzinga broke the news in New York, United States on Monday, January 20, 2025.
Sources are mostly out of (0)

Similar News Topics

Europe

Europe

Business

Business

Shanghai, China

Shanghai, China

China Economy

China Economy

European Economy

European Economy

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal